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Binding of misonidazole to hypoxic cells in monolayer and
spheroid culture: Evidence that a side-chain label is bound
as efficiently as a ring label
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Summary The binding of ring-labelled and side-chain labelled misonidazole to hypoxic cells in monolayer
and spheroid cultures of mammalian cells has been compared. The kinetics and patterns of binding for the
two labelled compounds are indistinguishable. This finding has implications for the mechanism of binding and
for the design of misonidazole analogues which might be used to identify hypoxic zones in tumours.
Labelled 2-nitroimidazole radiosensitizers might be
used to identify hypoxia in tumours by virtue of
their ability to bind to hypoxic cells (Chapman et
al., 1981). Binding would be detected by 2-
nitroimidazoles labelled with markers such as 14C
(Varghese & Whitmore, 1980; Chapman et al.,
1981; Franko & Chapman, 1982; Franko et al.,
1982; Chapman et al., 1983; Franko & Koch,
1984), y-emitting halogens (Rasey et al., 1982; Jette
et al., 1983) and fluorescent moieties (Olive &
Durand, 1983). For the design of suitably labelled
compounds it is of interest to know if labels in the
side chain of compounds related to misonidazole
(III, Figure 1), are retained in the binding process,
given that reductive activation of misonidazole
(MISO) in model systems can lead to extensive
fragmentation of the 2-nitroimidazole ring
(Whillans & Whitmore, 1981; Koch et al., 1982;
Knox et al., 1983; Raleigh & Liu, 1983, 1984)
including a major fragmentation route which leads
to the elimination of the side chain from the
original MISO molecule (Figure 1, compound VIII)
(Raleigh & Liu, 1984). Using MISO specifically
labelled in the side chain with tritium to a high
specific activity (Born & Smith, 1983), we have
investigated the question of whether a side chain
label is retained during MISO binding in single cells
and spheroid cultures. MISO acetate is of interest
in this study in connection with the role that the
side chain hydroxyl group in MISO may play in the
binding process.
Materials and methods
Labelled misonidazole
The synthesis of 2-[3H]- 1-(2-hydroxy-3-methoxy-
propyl)-2-nitroimidazole (II Figure 1), was achieved
according to a published procedure (Born & Smith,
1983). Typically avial oftritiated sodiumborohydride
(NaB[3H]4; 100mCi, 14Cimmol-1, New England
Nuclear) was opened and 150jul of absolute ethanol
containing 8mg of 1-(3-methoxy-2-oxopropyl)-2-
nitroimidazole (I) was added. Compound I was
prepared by chromic acid oxidation of MISO
(Beaman et al., 1968). The top portion of the vial
containing the NaB[3H]4 was washed with 100,l of
absolute ethanol. This was added to the reaction
mixture. After 2.5h at room temperature the violet-
colored reaction mixture was filtered through glass
wool into a test tube which contained 250mg of
unlabelled MISO. The glass wool was washed with
700,l of ethanol and the resulting mixture heated
on a hot water bath to complete solution. The
solution was then cooled in an ice bath to ensure
complete crystallization of labelled MISO. The
crystals were dissolved in 7ml of absolute ethanol.
The concentration of tritium labelled MISO was
determined by spectrophotometry to be 0.166
molar. The radiochemical purity of freshly prepared
II as determined by thin layer chromatography
(ethyl acetate solvent, Silica Gel plates) was 93%.
The specific activity was measured to be
3491iCimg-'. [3H]-labelled MISO acetate in which
the side chain hydroxyl group is acetylated was
prepared from [3H]-MISO as described previously
for unlabelled MISO acetate (Raleigh et al., 1982).
Ring-labelled radioactive MISO [14C-2] was
provided to us by Dr J.D. Chapman through the
generous auspices of Dr W.E. Scott at Hoffman-
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Figure 1 Synthesis of2-[3H]-1-(2-hydroxy-3-methoxypropyl)-2-nitroimidazole (upper panel) and molecular (IV,
V) and fragmentation (VI-X) products formed from MISO following reductive activation (lower panels).
La Roche Inc. (Nutley, NJ). The specific activity was
230pCimg-' and the radioactive purity was
>90%. Contaminants were not responsible for
the binding reported herein, since it was possible
to competitively inhibit binding using purified
unlabelled MISO.
Cells in monolayer culture
The culturing and experimental methods used in
these experiments have been described previously
(Koch, 1984; Koch et al., 1984a). Briefly, V-79-
WNRE cells were maintained in exponential growth
phase using Eagle's minimal essential medium
(MEM) supplemented with 13.5% V/V foetal calf
serum and antibiotics (MEM; cell medium
components from Gibco). The afternoon before an
experiment, cells were inoculated onto the central
area of glass petri dishes (- 105cells cm 2) and
incubated overnight at 37°C in a water jacketed
incubator in 95% air, 5% CO2 (100% relative
humidity). On the morning of the experiment, drugs
(if required, i.e. combinations of radioactive and
non-radioactive sensitizers) were added to MEM
containing 20mM HEPES buffer (pH 7.4) and 1/5
normal bicarbonate (4.5mM). The medium on the
dishes was aspirated and then the experimental
medium was added, first as a 0.3 ml rinse which
was also aspirated and then as a final 1 ml to be
used for the experiment. The dishes were placed in
aluminum leak-proof chambers and the air in the
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chambers was replaced with gas containing that of
the desired oxygen content via a series of gas
changes. Estimates of the effect of cellular
metabolism on the actual oxygen concentrations at
the cell monolayer have been published (Koch,
1984) but all oxygen concentrations reported here
refer to gas phase values.
After the gas phase of the chambers had reached
the desired oxygen level (30min at room
temperature), the chambers containing the dishes
with cells were incubated at 37°C in a forced air
incubator. Temperature equilibrium was established
after 30min. At various times the chambers were
removed from the incubator, the oxygen content of
the chamber was tested (Koch et al., 1984b) and the
chambers were opened and dishes removed. The
radioactive medium was removed, the dishes were
rinsed twice with 3ml of medium and then an
additional 3ml (chase medium) was added (all
additions non-radioactive). The dishes were then
incubated at 37°C for 15min in air to allow non-
metabolized radioactive MISO to leave the cells. It
was established that this rinsing procedure left only
background amounts of unbound radioactivity on
dishes (Koch et al., 1984a).
Each dish was cooled on ice and the chase
medium was removed. The dish was then rinsed
with ice cold PBS and the cells were scraped
into 1.5ml of 5% TCA. This suspension was added
to a centrifuge tube and the dish was rinsed with an
additional 1.0ml of TCA which was also added to
the centrifuge tube. The tube was spun at 2500rpm
at 0°C for 20min and the supernatant was added to
a liquid scintillation vial containing 10ml of
Scintiverse (Fisher). This sample was considered to
contain acid soluble bound products of the
metabolism of MISO. The TCA insoluble pellet
was solubilized by incubating at room temperature
in 0.3ml of 1N NaOH for 1 h with vortexing at
30min. The base was neutralized and the sample
centrifuged as above and added to another
scintillation vial containing Scintiverse. This sample
was considered to contain acid precipitable bound
products of the metabolism of MISO. The samples
were counted in a Beckman Scintillation Counter
with correction for quenching.
Each experiment contained a set of dishes which
was incubated in extreme hypoxia with 20,uM 14C-
MISO. The rate of binding (-3,000cpm 10-6
cellsh-1) for this standard condition was taken
to be unity and the rate of binding for all other
concentrations and conditions was compared with
this standard. Therefore, the normalized rate for
any condition and total concentration of MISO was
computed as:
R= (observed rate) x (relative fraction of
radioactive : non-radioactive MISO)1 x (rate
for extremely hypoxic cells at 20pM) 1
all rates being expressed as cpm 10 6 cells per hour
of incubation (Koch et al., 1984a).
In previous work it was found that one could
equally compare rates of binding for the acid
soluble as for the acid precipitable bound products
(Koch et al., 1984a). That is, there were no
differential effects of oxygen concentration or
MISO concentration on the acid soluble versus
insoluble fraction of bound material. Therefore, the
data shown in this paper were computed from the
total amount of bound material.
Spheroids
EMT6/Ed spheroids were initiated by seeding
2 x 105 cells in 60mm non-tissue culture dishes
(Lab-tek) in Waymouth's medium with 12% (v/v)
foetal calf serum. After 10 days, 103 spheroids
100 to 300pm in diameter were transferred into a
250ml spinner flask (O.H. Johns) containing 100ml
of medium and a gas phase of 3% CO2-97% air.
The medium was partially replenished on the 13th
day. On the 14th day 25 spheroids 700 to 800gm in
diameter were placed in each of several 250ml
spinner flasks in 50ml medium and the medium
was replenished daily. This procedure has been
shown to yield spheroids in which roughly 25% of
the cells are radiobiologically hypoxic on the 18th
day (Franko & Koch, 1983). On this day, the
spheroids were incubated with 25pM [3H]-MISO,
specific activity 349pCimg-' or 25pM 14C-MISO,
sp. act. 230pCimg- . For incubation in the growth
condition (air) the MISO was added to each flask
in 0.25ml of medium. The time of incubation was
3h. For incubation at 4000ppmO2 spheroids were
placed in glass petri dishes in 5ml of medium
containing 25pM MISO and 20mM HEPES buffer
at 0°C. The dishes were placed in an aluminum
leak-proof chamber and deoxygenated to the
desired oxygen level with a series of gas changes as
described above. Then the aluminum chamber
containing the petri dishes was placed on a shaker
plate (70shakesminm 1, 3cm travel) in an
environmental chamber at 37°C. The medium in the
dishes reached gas-phase equilibrium during the
30min required to warm to 37°C. Incubation of the
dishes was continued for an additional 3h. The
spheroids were then removed, washed in saline,
fixed in 10% buffered formalin overnight,
embedded in paraffin and sectioned at 4pm. The
slides were dipped in NTB2 nuclear track emulsion
(Kodak) and exposed for 16 days. The sections
were stained through the emulsion with
haematoxylin and eosin. Grains were scored using a
10x10 m grid aligned along a spheroid radius
which was perpendicular to the direction of
sectioning in order to minimize the effects of
compression of the section.232 J.A. RALEIGH et al.
Results
Previous results [14C]-MISO (Koch et al., 1984a)
have shown that the quantity of bound products of
MISO metabolism increased linearly with time of
incubation (times up to 8 h were tested) for all
conditions of drug concentration (0.005-1 mM
tested) and oxygen concentration (0-210,pM). At
zero oxygen concentration, the rate of binding was
proportional to the square root of MISO
concentration as shown by Chapman et al. (1983),
whereas with the addition of as little as 2pM
oxygen this rate, in addition to being much
reduced, was directly proportional to the MISO
concentration. Our results using 3H side chain
labelled MISO parallel those obtained with 14C ring
labelled MISO with no significant differences in the
binding observed (Figure 2). Although the data are
less complete, there is also no difference in the
kinetics of binding using [3H]-MISO with the side-
chain hydroxyl replaced by acetate.
The results for binding of [3H]- and [14C]-MISO
to EMT6/Ed spheroids are shown in Figure 3.
Each point is the mean of 20 counts from 10
different spheroids. Grain densities were recorded
only for the outer 200,pm of spheroids incubated in
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Figure 2 The rate of binding of 3H side chain labelled
MISO or MISO acetate to V79-WNRE Chinese
hamster cells as a function of drug concentration (all
relative to the rate of extremely hypoxic cells at
20pM). Previous data using '4C2 ring-labelled MISO
are summarized by the lines for zero oxygen
concentration (solid line), 2pM oxygen (dashed line)
and 7ptM oxygen (dotted line). The present data
represent the binding of 3H side chain labelled MISO
at zero oxygen concentration (0); [3H]-MISO acetate
at zero oxygen concentration (0); and [3H] MISO at
4p,M oxygen concentration (D).
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Figure 3 Binding of labelled MISO to EMT6/Ed spheroids. Typical 95% confidence intervals are indicated
by the error bars. Dotted line: 3H in air. Dashed line: 14C in air. Thick solid line: 3H in 4000ppm 02. Thin
solid line: 14C in 4000ppm 02. Note that the scales for the 3H and 14C grain densities are on opposite sides of
the figure.
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4000 ppm 02 since the region of interest is the outer
100,m. For spheroids in air, grain densities beyond
250,um were excluded because few intact cells were
found beyond this depth. The necrotic material is
not retained during the histological procedures
employed, so the quantity of MISO bound to
necrosis was not obtained. The scales for 3H and
14C were chosen to equalize the binding at
4000ppm. The 3-fold difference in grain density is
consistent with equal binding rates for [3H]- and
[14C]-MISO if a correspondingly reduced detection
efficiency for 3H is assumed. This seems reasonable
because the average penetration range in tissue of
beta particles from 3H is roughly 25% of the
thickness of the sections, while the range of beta
particles from 14C is greater than the section
thickness (Baserga & Malamud, 1969).
Discussion
The data presented here provide a comparison of
the binding of the C2-ring and side chain portions
of MISO. Three different properties can be
compared: the absolute binding rate, the oxygen
concentration dependence of the inhibition of
binding by oxygen and the diffusion of reactive
metabolites of MISO away from the cells which
metabolize it.
The absolute binding rates of 3H and 14C appear
to be identical. This is seen in the monolayer data
where the counting efficiencies can be accurately
calculated by standard liquid scintillation
techniques. The spheroid data are not inconsistent
with this conclusion if a reasonable assumption
regarding the detection efficiencies of 3H and 14C is
made although the main point of the spheroid data
was to show that the pattern of binding from the
spheroid surface to its interior was the same.
The oxygen dependence of binding to monolayer
cultures was investigated in detail previously for
[14C]-MISO (Koch et al., 1984a). These data are
reproduced in Figure 2, with additional data for
[3H]-MISO and [3H]-MISO acetate. The key
features of the oxygen dependence of the binding
rate are the kinetic change from half to first order
with respect to MISO concentration at low oxygen
concentration and the overall decrease in binding
rate as the oxygen level increases. While these
changes in binding as a function of MISO and
oxygen concentration are complex, the fact that
they are identical for both ring-labelled and side-
chain labelled MISO shows that a side-chain label
is bound as efficiently as a ring-label under a wide
range of oxygen levels. The half order binding
kinetics found for both side-chain labelled
misonidazole and misonidazole-acetate (Figure 2)
are particularly interesting. Chapman & Lee (1984)
have shown that another sensitizer, SR-2508, in
contrast to MISO, has first order binding kinetics
under conditions of extreme hypoxia and we have
confirmed this result using our methods (data not
shown). Both drugs are 2-nitroimidazoles but a key
difference in the side-chain is the absence of a
hydroxyl group at the 2nd carbon position of the
side-chain for SR-2508
(MISO: -CH2-CHOH-CH2OCH3,
SR-2508: -CH2-CO-NHCH2CH20H).
It seemed possible that the hydroxyl group could
affect the overall chemical reactivity of the ring
after reduction, and that by substituting an acetate
on the side chain
0
11
(CH2-CH(OCCH3)-CH2OCH3)
this effect could be masked. The fact that MISO
acetate has binding kinetics similar to MISO rather
than to SR-2508 suggests that another factor must
be involved.
The oxygen dependence of binding in the
spheroid also appears to be identical for [14C]- and
[3H]-MISO. This is best seen in the patterns of
binding at 4000ppm. Comparison of the grain
density at depths >100,m, where cells should be
severely hypoxic, with the grain density over the
outermost cell layer indicates that 4000ppm 02
inhibits 'binding in both cases by 40%. While
incubation in severe hypoxia to quantitate directly
the degree of inhibition in 4000ppm02 was not
performed in this work, it was found previously
that binding of [14C]-MISO is uniform across the
entire rim of viable cells if incubation is performed
in severe hypoxia (Franko et al., 1982). In addition
to this similar inhibition at the spheroid surface, the
profiles of the binding across the outer 50tm,
across which the 02 concentration is expected to
fall from 4000 ppm to near zero, are identical
within experimental error. This conclusion depends
only on the patterns of binding and is not affected
by the uncertainty in the relative detection
efficiency of 3H and 14C. In air the patterns of
binding to spheroids are almost identical except for
a slight difference in the distance from the spheroid
surface at which the binding rate rises abruptly.
Such a difference would not be unexpected,
considering the variability observed in the
radiobiologically hypoxic fraction (Franko & Koch,
1983). The fact that the rise in binding occurs over
a similar distance in both cases is good evidence
that the oxygen dependence of binding of the two
compounds is identical in the spheroid. This234 J.A. RALEIGH et al.
conclusion is potentially relevant to the use of
labelled MISO in vivo because the spheroid
provides a complex range of cellular micro-
environments which is difficult to simulate in mono-
layer culture and which likely models some aspects
of tumor tissue (Sutherland & Durand, 1976).
Limited diffusibility of the reactive metabolite(s)
of MISO responsible for covalent binding to
cellular constituents is an important property if the
compound is to be useful for the identification of
hypoxic cells in tissue sections. Several different
experimental approaches indicate that most of the
[14C]-MISO label is bound to the cells in which the
metabolic conversion occurs (Franko et al., 1982;
Chapman et al., 1983; Franko & Koch, 1984). The
data in this paper demonstrate that the reactive
metabolites of [3H]- and [14C]-MISO have similar
diffusion characteristics. The fact that the rates of
binding of [3H]- and [14C]-MISO to monolayer
cultures are identical (Figure 2) suggests this
conclusion, although more complex interpretations
are possible. The patterns of binding to spheroids
(Figure 3) also indicate identical properties for the
diffusion of reactive metabolites in that the shapes
of the curves over the range from minimal to
maximal binding are identical. The uncertainty in
the detection efficiency of 3H and 14C does not
affect this conclusion.
The exact nature of the reactive metabolites of
MISO which bind to hypoxic cells is not known but
one possible interpretation of the similar kinetics
and binding patterns for ring-labelled and side-
chain labelled MISO is that the binding molecule
incorporates both ring and side-chain carbon atoms
of the original MISO structure. In the context of
what is presently known about the reductive
activation of MISO, this could be achieved if the
hydroxylamine derivative of MISO (IV) were to
bind to cellular sulphydryl and amino groups in a
manner (V) analogous to that proposed for the
binding of glutathione to reduced MISO (Varghese,
1983; Smith & Born, 1984). Alternatively, binding
could occur with precursors to the hydroxylamine
such as radical intermediates (Koch et al., 1984a) or
nitroso precursors although specific attempts to
trap the nitroso intermediate have not been
successful (Raleigh et al., 1981). Reactive inter-
mediates from the fragmentation of reductively
activated MISO such as aldehydes (Raleigh & Liu,
1984) could account for the binding observed if the
fragments derived from the ring and those derived
from the side chain were to have similar binding
efficiencies and diffusion properties. Major
fragments from the breakup of reduced MISO
which incorporate the side chain, however, have no
obvious covalent binding capacity (VII and VIII,
Figure 1) (Koch et al., 1982; Raleigh & Liu, 1984)
and glyoxal (VI), a major ring fragment with
considerable binding potential, (Liu & Raleigh,
1982; Raleigh & Liu, 1984), would not be labelled
in the present experiments because it is derived
from carbon atoms of 4 and 5 of MISO whereas
the 14C label is at position 2 of the MISO ring
(Figure 1).
In summary, the results of this investigation
indicate that, in principle, a side-chain label in
MISO will be bound to hypoxic cells as efficiently
as a ring label. We believe the results are consistent
with "molecular" products such as IV being
involved in the binding process but cannot rule out
a contribution from fragmentation products of
reductively activated MISO. From a practical point
of view, the results are seen as being useful to the
design of hypoxic cell markers which are based on
the reductive metabolism of MISO and its
analogues.
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